BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9633822)

  • 1. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
    Hrzenjak M; Shain SA
    Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
    Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
    Hrzenjak M; Shain SA
    Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
    Shain SA
    Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells.
    Gu X; Seong GJ; Lee YG; Kay EP
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2326-34. PubMed ID: 8843917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
    Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
    Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.
    Sauma S; Yan Z; Ohno S; Friedman E
    Cell Growth Differ; 1996 May; 7(5):587-94. PubMed ID: 8732668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPA-induced signal transduction: a link between PKC and EGFR signaling modulates the assembly of intercellular junctions in Caco-2 cells.
    Barbosa LA; Goto-Silva L; Redondo PA; Oliveira S; Montesano G; De Souza W; Morgado-Díaz JA
    Cell Tissue Res; 2003 Jun; 312(3):319-31. PubMed ID: 12733059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin.
    Garg R; Ramchandani AG; Maru GB
    Carcinogenesis; 2008 Jun; 29(6):1249-57. PubMed ID: 18477648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
    J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
    Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
    Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
    Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
    Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
    J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells.
    Sato H; Ogata H; De Luca LM
    Oncogene; 2000 Jun; 19(25):2904-12. PubMed ID: 10871841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells.
    Xu KP; Dartt DA; Yu FS
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3673-9. PubMed ID: 12454035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.